Showing results (561-570 of 3,096) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|October 14, 2014
PI3K/AKT/mTOR pathway inhibitors: the ideal combination partners for breast cancer therapies?Jame AbrahamExpert Review of Anticancer Therapy|March 19, 2026
Radiotheranostics in solid tumours: focus on radiopharmaceutical therapy and clinical challengesLucente Daniela, Stefania Bellino, Anna La SalviaExpert Review of Anticancer Therapy|June 3, 2026
Antibody-drug conjugates: a practical review on clinical management of toxicitiesAntonio De Palma, Marco Marenco, Sofia Mancini, et al.Expert Review of Anticancer Therapy|June 29, 2011
Breast care in 2011 and beyond: state of policy, state of scienceJennifer Gass, John Bell, Don S DizonExpert Review of Anticancer Therapy|June 14, 2023
Impact of Quality Control Circle on Patient Outcomes after Hepatocellular Carcinoma Intervention: A Meta-AnalysisYimin Wang, Yuerong Lai, Li Du, et al.Expert Review of Anticancer Therapy|February 1, 2006
Cost-effective treatment options in first-line therapy for advanced breast cancer in JapanMasahide Kondo, Masakazu ToiExpert Review of Anticancer Therapy|June 10, 2026
Local treatment of the primary tumour in mHSPC in the ARPI era: incremental value or overtreatment?Simone Rota, Melanie Claps, Eleonora Gusmaroli, et al.Expert Review of Anticancer Therapy|April 24, 2026
Neoadjuvant treatment regimens associated with pathological complete response in triple-negative breast cancer: a systematic review and network meta-analysisBrenda Luana Rocha Soares Menegat, Ana Luíza Rocha Soares Menegat, Maria Victória Ferreira Piccoli, et al.Expert Review of Anticancer Therapy|May 6, 2026
Quantitative and qualitative faecal immunochemical tests for colorectal cancer screening in Kazakhstan: a comparative studyAbay Jumanov, Dilyara Kaidarova, Alma Zhylkaidarova, et al.Expert Review of Anticancer Therapy|May 7, 2026
LUMINATE-101-Maccabi: a real-world study of treatment patterns and clinical outcomes in patients with non-squamous metastatic non-small cell lung cancer in an Israeli health maintenance organization (HMO)Sarah Sharman Moser, Alona Zer, Andre Hejazi, et al.Pageof 310